Authors/Disclosures
|
|
No disclosure on file |
|
Alison L. Walsh, MD
(Lehigh Valley Health Network)
|
Dr. Walsh has nothing to disclose. |
|
|
No disclosure on file |
|
Philip A. Wolf, MD, FAAN
|
No disclosure on file |
|
Anthony T. Allen II, MD
(SCPMG)
|
No disclosure on file |
|
Sudha Seshadri, MD, FAAN
(Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases)
|
Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Alexa Beiser
|
Alexa Beiser has nothing to disclose. |
|
Rhoda Au, PhD
(Boston University School of Medicine)
|
Dr. Au has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Au has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Au has received publishing royalties from a publication relating to health care. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Davos Alzheimer's Collaborative. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with High Lantern. |
|
|
No disclosure on file |
|
Charles S. DeCarli, MD, FAAN
(UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center)
|
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH. |